RE F
R
OM
RKERSThe University of Manchester is a recognised world leader in cancer research. We are fundraising for a new and unique £34.5m research centre which will bring scientists and doctors together to develop and test new methods to beat cancer by personalising treatments for each individual patient.
Cancer biomarkers are substances that doctors can search for and measure, most often in blood samples. Biomarkers hold the key to understanding how individual cancer patients differ.
If we are to realise the potential of precision medicine in cancer, we need translational scientists and hospital doctors to work hand in hand.
Our new centre will take its place among the world elite as one of only a handful of institutions pioneering this approach in an exciting new era of precision medicine.
